Avid Bioservices, a biologics CDMO, has opened a second downstream processing suite within the company's existing Myford North facility. This new suite was constructed as the first phase of the company's two-part Myford facility expansion. Avid has completed its validation of equipment and is now actively scheduling new business into the suite. Avid also recently announced plans for a strategic expansion into the cell and gene therapy market with a purpose-built 53,000 sqft viral vector development and cGMP facility.
展开▼